| Name | Title | Contact Details |
|---|
Rice is a private, independent university dedicated to the "advancement of letters, science, and art." Rice attracts a diverse group of highly talented students with a range of academic studies that includes humanities, social sciences, natural sciences, engineering, architecture, music, and business management. The school offers students the advantage of forging close relationships with members of the faculty and the option of tailoring graduate and undergraduate studies to their specific interests. The Electrical and Computer Engineering Department provides high quality undergraduate and graduate degree programs, which emphasize fundamental principles that respond to and create technological change.
Law Offices of Paul Chatzky is a Northfield, IL-based company in the Business Services sector.
Nekoosas mission is to manufacture and convert the highest quality specialty print media substrates for the commercial print and graphics markets. The partnership of Nekoosa Coated Products, RTape, Catalina Graphic Films and CET Films allows Nekoosa to deliver excellence across its product portfolio and create new opportunities for our customers. Nekoosas strong legacy of manufacturing and converting specialty products began over 60 years ago as a division of 3M. Nekoosa has since evolved into a key supplier of visual communication products including wide and grand format rolls; offset, screen, HP Indigo and dry toner sheets; cut films; application tapes and premasks; carbonless papers and extruded films. The simple mission statement that guides us is, ‘Whats New…". We pride ourselves in being ‘different, which means we are energetic, innovative and take a sustainable approach to ensure that everything we do leaves a positive impact on our team members, customers and communities.
The SmartVest Airway Clearance System is HFCWO therapy that helps people breathe better. Learn about our treatment option for COPD and bronchiectasis.
Antibody and protein biotherapeutics are changing the way physicians treat autoimmune diseases, asthma, and cancer. At Xencor, we apply proprietary protein engineering technologies to develop better biotherapeutics – antibodies that target new biological mechanisms and are more potent, safer and longer lasting – to improve patient outcomes and quality of life. Our XmAb antibody engineering technology dramatically augments natural antibody immune functions while maintaining over 99.5% identity to natural antibodies. This combination of new, highly potent activities while maintaining the beneficial drug features and simplicity of natural antibodies allows us to create differentiated drug candidates with potential for breakthrough performance. The XmAb® platform has resulted in a robust pipeline of antibody product candidates, including eight in human clinical trials being developed by Xencor and by pharmaceutical partners. Xencor is also discovering biologics products that improve the performance of old antibody drugs, known as biosuperiors, to benefit patients, ease compliance and help reduce costs.